An indoline-derived compound that markedly reduces mouse body weight.
M Tercel1, R N Marnane, M A Tatnell
1Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences (FMHS), University of Auckland, Auckland, New Zealand.
International Journal of Obesity (2005)
|June 27, 2012
Summary
A novel indoline-derived drug significantly reduced body weight and fat mass in mice. This drug also reversed obesity and type 2 diabetes, suggesting potential for new obesity treatments.
Area of Science:
- Pharmacology
- Metabolic Diseases
- Toxicology
Background:
- Obesity and type 2 diabetes are significant global health challenges.
- Current treatments have limitations, necessitating novel therapeutic approaches.
Purpose of the Study:
- To investigate the effects of an indoline-derived drug (SN 28127 and its analog SN 29220) on body weight, adipose tissue mass, and metabolic parameters in mice.
- To explore the potential of this drug class as a novel therapeutic strategy for obesity and related metabolic disorders.
Main Methods:
- Administration of indoline-derived drugs (SN 28127, SN 29220) via intraperitoneal injection.
- Assessment of body weight, adipose tissue mass, food intake, and blood glucose levels.
- Pharmacokinetic studies using radiolabeled SN 29220 and analysis of gene expression related to fatty acid synthesis and appetite.
Main Results:
- A single injection of SN 28127 caused significant and sustained reductions in body weight (25-45%) and adipose tissue mass (~75%).
- SN 29220 reversed diet-induced obesity and type 2 diabetes, improving insulin sensitivity and reducing blood glucose.
- Drug distribution studies indicated the liver as a primary target, with observed changes in glucose and lipid metabolism genes.
Conclusions:
- Indoline-derived drugs induce chronic toxicity to the hepatic system, leading to reduced white adipose tissue mass and body weight.
- These findings suggest a potential therapeutic window for indoline-derived compounds in managing obesity and type 2 diabetes.
- Further research into the molecular mechanisms could identify novel targets for obesity prevention and treatment.
